| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1248735C Preparing method and usage of cardiotoxin |
| 04/05/2006 | CN1248728C Traditional Chinese medicine for treating psychosis |
| 04/05/2006 | CN1248709C Chinese medicine preparation for stopping drug addiction |
| 04/05/2006 | CN1248708C Chinese medicine for treating catatonic type headache |
| 04/05/2006 | CN1248689C Injectable bupernorphine microparticle compositions and their use |
| 04/04/2006 | US7022893 Knockin gene-mutated mouse comprising a mutant presenilin-1 gene |
| 04/04/2006 | US7022881 formed by spray drying an aqueous solution, heating/crystallization, suspension/filtration, or acidification/filtration |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022732 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022709 Producing pharmaceuticals for improving perception, concentration, learning and/or memory. |
| 04/04/2006 | US7022708 Serotonin receptors antagonis; antidepressants; central nervous system disorders; Parkinson's disease; huntington's disease; Alzheimer's disease |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022701 for treatment of disorders (sleeping, feeding) relating to or affected by the 5-HT6 receptor; serotonin receptor antagonists |
| 04/04/2006 | US7022698 Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof |
| 04/04/2006 | US7022697 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 04/04/2006 | US7022694 Indoles and indolines having 5-HT activity |
| 04/04/2006 | US7022692 comprises water soluble binder and sweetener; for treating central nervous system disorders such as psychotic disease conditions including schizophrenia |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 04/04/2006 | CA2354123C New benzothiadiazine derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/04/2006 | CA2291075C Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2103022C Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 03/30/2006 | WO2006034089A1 Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 03/30/2006 | WO2006033631A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 03/30/2006 | WO2006033630A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | WO2006033627A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 03/30/2006 | WO2006033386A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 03/30/2006 | WO2006033341A1 Therapeutic or preventive agent for diabetic neuropathy |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006033007A2 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 03/30/2006 | WO2006033000A2 N-ethyl hydroxyethylamine useful in treating cns conditions |
| 03/30/2006 | WO2006032481A1 Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| 03/30/2006 | WO2006032459A1 Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| 03/30/2006 | WO2006032273A1 2-acylaminothiazole derivatives |
| 03/30/2006 | WO2006000912A3 Pyridyl piperazines for the treatment of cns disorders |
| 03/30/2006 | WO2005103710A3 Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 1 (crhr1) |
| 03/30/2006 | WO2005102316A3 Use of coumarin derivatives |
| 03/30/2006 | WO2005097192A3 Active substance combination of a carbinol compound and an opioid |
| 03/30/2006 | WO2005040169A3 Fused heterocyclic compounds as serotonin receptor modulators |
| 03/30/2006 | WO2004096199A3 Regulation of guanine nucleotide exchange factor |
| 03/30/2006 | US20060069264 Aza hydroxylated ethyl amine compounds |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069147 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease |
| 03/30/2006 | US20060069146 Cardiovascular disordders; antiarrhythmia agents; neurodegenerative diseases; antidepressants; bipolar disorders; irritable bowel disorders |
| 03/30/2006 | US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069113 Analgesic compositions containing buprenorphine |
| 03/30/2006 | US20060069111 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome |
| 03/30/2006 | US20060069107 Method of treating behavioral disorders |
| 03/30/2006 | US20060069104 Neurotrophic factor production accelerator |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069039 Treatment of dyskinesia |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060068045 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 03/30/2006 | US20060068027 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 03/30/2006 | US20060067982 Encasing a core made of a siloxane-based elastomer containing dexamethasone, betamethasone, beclomethasone, and/or budesonide with a membrane made of the same or a different elastomer; and shaping the device into a shape suitable for implantation into the ear or nose |
| 03/30/2006 | DE112004000762T5 Verwendung von Triglyceridölen, die gamma-Linolensäurereste und Linolsäurereste enthalten, zur Behandlung von neurodegenerativer Krankheit The use of triglyceride oils, the gamma-linolenic acid and linoleic acid residues contained, for the treatment of neurodegenerative disease |
| 03/30/2006 | DE102004043938A1 Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 03/30/2006 | DE102004039011A1 Extract, useful to prepare a medicament to treat e.g. gastrointestinal pain, cramps of urogenital tracts, asthma, cough and headache, comprises Petasites hybridus extract, that is free of pyrrolizidine alkaloid and furanoeremophilane |
| 03/30/2006 | CA2582512A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 03/30/2006 | CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | CA2581143A1 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| 03/30/2006 | CA2581128A1 Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| 03/30/2006 | CA2581105A1 2-acylaminothiazole derivatives |
| 03/30/2006 | CA2581083A1 Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| 03/30/2006 | CA2580981A1 Stabilized human igg4 antibodies |
| 03/30/2006 | CA2580775A1 N-ethyl hydroxyethylamine useful in treating cns conditions |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580265A1 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |